U.S.A.Drugs Private Limited - Company Profile

It is a pharma private limited company based in Saharanpur, Uttar Pradesh, India, established in 2002.
2002 Saharanpur, Uttar Pradesh, India Struck Off
Last Updated:
Access Report
About U.S.A.Drugs Private Limited

U.S.A.Drugs Private Limited, a struck off private limited company, was established on 18 July 2002 in Saharanpur, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397UP2002PTC026808. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.30 M.

Its leadership includes Varun Singh (Director), Amit Singh (Director), Hoshiyar Singh (Director). Its latest AGM occurred on 29 September 2011, with the balance sheet filed on 31 March 2011. It is based at 459 G T Road Manglore Chowki Deoband, Saharanpur, Uttar Pradesh, 247001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397UP2002PTC026808

  • Registration Number

    026808

  • Incorporation Date

    18 July 2002

  • Authorized Capital

    ₹0.30 M

  • Paid-Up Capital

    ₹0.30 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.30 M
  • Paid Up Capital ₹ 0.30 M
  • Company Age 23 Year, 10 Months
  • Last Filing with ROC 31 Mar 2011
Company report

U.S.A.Drugs Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into U.S.A.Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at U.S.A.Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Varun Singh Director 18 Jul 2002 Current
Amit Singh Director 18 Jul 2002 Current
Hoshiyar Singh Director 18 Jul 2002 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of U.S.A.Drugs.

Enhance accessibility to U.S.A.Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

U.S.A.Drugs revenue growth over time
U.S.A.Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of U.S.A.Drugs?

Unlock access to U.S.A.Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at U.S.A.Drugs?

Unlock and access historical data on people associated with U.S.A.Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of U.S.A.Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped U.S.A.Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on U.S.A.Drugs
Recent Activity within the Organization
  • Annual General Meeting

    U.S.A.Drugs Private Limited last Annual general meeting of members was held on 29 Sep 2011 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity U.S.A.Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Kanpur. was completed.

  • Director Appointment

    Varun Singh was appointed as a Director was appointed as a Director on 18 Jul 2002 & has been associated with this company since 23 years 10 months . was recorded as a recent event.

  • Director Appointment

    Progress on Amit Singh was appointed as a Director was appointed as a Director on 18 Jul 2002 & has been associated with this company since 23 years 10 months . was documented.

  • Director Appointment

    Hoshiyar Singh was appointed as a Director was appointed as a Director on 18 Jul 2002 & has been associated with this company since 23 years 10 months . was recorded as a recent event.

  • Company Incorporation

    The activity U.S.A.Drugs Private Limited was registered on 18 Jul 2002 with Roc Kanpur & aged 23 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of U.S.A.Drugs Private Limited?

The CIN of U.S.A.Drugs Private Limited is U51397UP2002PTC026808.

Where is U.S.A.Drugs Private Limited headquartered?

U.S.A.Drugs Private Limited is headquartered at 459 G T Road Manglore Chowki Deoband, Saharanpur, Uttar Pradesh, 247001.

When was U.S.A.Drugs Private Limited incorporated?

U.S.A.Drugs Private Limited was incorporated on 18 July 2002.

Who are the current directors of U.S.A.Drugs Private Limited?

The current directors of U.S.A.Drugs Private Limited are

What is the primary industry of U.S.A.Drugs Private Limited?

The primary industry of U.S.A.Drugs Private Limited is Pharma.

Is U.S.A.Drugs Private Limited a listed company?

U.S.A.Drugs Private Limited is unlisted.

What is the capital structure of U.S.A.Drugs Private Limited?

The authorized capital of U.S.A.Drugs Private Limited is ₹0.30 M, and the paid-up capital is ₹0.30 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available